Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Chabannon

Showing results (1-10 of 229) with videos related to

Pageof 23
Sort By:
Medecine Sciences : M/S|May 12, 2005
[Happy birthday, CD34!]Christian Chabannon
Current Research in Translational Medicine|April 8, 2018
Considerations pertaining to cell collection and administration of industry-manufactured autologous CAR-T cells, in relation to French healthcare organization and regulationsChristian Chabannon, Jérôme Larghero
Bulletin Du Cancer|January 29, 2019
Christian Chabannon, Jérôme Larghero
Medecine Sciences : M/S|April 13, 2012
[Clinical research and human and social sciences at Cancéropôle PACA]Christian Chabannon, Roch Giorgi
Journal International De Bioethique Et D'Ethique Des Sciences|February 16, 2019
[Chapter 6. Legal issues and for the health system of the development of a new class of innovative therapy in oncoimmunology: the “Car-T CellS”]Emmanuelle Rial-Sebbag, Christian Chabannon
Medecine Sciences : M/S|January 1, 2009
[Ikaros and erythropoiesis]Marilyne Dijon, Christian Chabannon, Cécile Tonnelle
Cytotherapy|May 28, 2020
Welcome to ISCT 2020 Paris VirtualChristian Chabannon, Rachele Ciccocioppo, Ivan Martin
Medecine Sciences : M/S|June 15, 2017
[The biological complexity of Polycomb group proteins: the case of EZH2]Myriam Koubi, Christian Chabannon, Estelle Duprez
Cytotherapy|February 22, 2020
Identification of hurdles in the development of cell-based therapiesAntonia Rotolo, Christian Chabannon, Roberto Gramignoli
Drug Discovery Today|January 11, 2018
From clinical proof-of-concept to commercialization of CAR T cellsBoris Calmels, Bechara Mfarrej, Christian Chabannon
Pageof 23

Showing results (1-10 of 229) with videos related to

Sort By:
Pageof 23
Medecine Sciences : M/S|May 12, 2005
[Happy birthday, CD34!]Christian Chabannon
Current Research in Translational Medicine|April 8, 2018
Considerations pertaining to cell collection and administration of industry-manufactured autologous CAR-T cells, in relation to French healthcare organization and regulationsChristian Chabannon, Jérôme Larghero
Bulletin Du Cancer|January 29, 2019
Christian Chabannon, Jérôme Larghero
Medecine Sciences : M/S|April 13, 2012
[Clinical research and human and social sciences at Cancéropôle PACA]Christian Chabannon, Roch Giorgi
Journal International De Bioethique Et D'Ethique Des Sciences|February 16, 2019
[Chapter 6. Legal issues and for the health system of the development of a new class of innovative therapy in oncoimmunology: the “Car-T CellS”]Emmanuelle Rial-Sebbag, Christian Chabannon
Medecine Sciences : M/S|January 1, 2009
[Ikaros and erythropoiesis]Marilyne Dijon, Christian Chabannon, Cécile Tonnelle
Cytotherapy|May 28, 2020
Welcome to ISCT 2020 Paris VirtualChristian Chabannon, Rachele Ciccocioppo, Ivan Martin
Medecine Sciences : M/S|June 15, 2017
[The biological complexity of Polycomb group proteins: the case of EZH2]Myriam Koubi, Christian Chabannon, Estelle Duprez
Cytotherapy|February 22, 2020
Identification of hurdles in the development of cell-based therapiesAntonia Rotolo, Christian Chabannon, Roberto Gramignoli
Drug Discovery Today|January 11, 2018
From clinical proof-of-concept to commercialization of CAR T cellsBoris Calmels, Bechara Mfarrej, Christian Chabannon
Pageof 23